Should Pregnant Women Get a Covid-19 Booster Shot?
Experts strongly agree that the shots benefit the mother as well as the fetus.
antibodies
Qué pasa si combino vacunas en la dosis de refuerzo
La FDA podría autorizar dosis de refuerzo de vacunas diferentes de los que los estadounidenses recibieron en sus primeras dosis. Hay evidencia científica prometedora que respalda la medida.
Qué pasa si combino vacunas en la dosis de refuerzo
La FDA podría autorizar dosis de refuerzo de vacunas diferentes de los que los estadounidenses recibieron en sus primeras dosis. Hay evidencia científica prometedora que respalda la medida.
Should Pregnant People Get a Covid Booster?
Experts strongly agree that the shots benefit the mother as well as the fetus.
Should Pregnant Women Get a Covid-19 Booster Shot?
Experts strongly agree that the shots benefit the mother as well as the fetus.
Mix-and-Match Covid Boosters: Why They Just Might Work
The F.D.A. may authorize booster shots of vaccines different from the ones that Americans originally received. The science behind the move is promising.
Mix-and-Match Covid Boosters: Why They Just Might Work
The F.D.A. may authorize booster shots of vaccines different from the ones that Americans originally received. The science behind the move is promising.
Study of Covid Booster Shot Benefits Fans Debate Over Extra Doses
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Study of Covid Booster Shot Benefits Fans Debate Over Extra Doses
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Study of Booster Shot Benefits Fans Debate Over Extra Doses
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
As Virus Cases Surge, Biden Administration Encourages More Use of Antibody Treatments
A top White House adviser said monoclonal antibody treatments, sometimes underused, could still be crucial in helping people with Covid-19 avoid getting very sick.
As Virus Cases Surge, Biden Administration Encourages More Use of Antibody Treatments
A top White House adviser said monoclonal antibody treatments, sometimes underused, could still be crucial in helping people with Covid-19 avoid getting very sick.
UK study raises hopes of long COVID test within months
A diagnostic test to detect long COVID could be available within six to 12 months, following the discovery that patients with the chronic condition have distinctive antibodies in their blood. Researchers at Imperial College London (ICL) led by Professor Danny Altmann told the BBC’s Panorama programme that they have identified a pattern of antibodies in …
UK study raises hopes of long COVID test within months Read More »
Should People With Immune Problems Get Third Vaccine Doses?
France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own.
Should People With Immune Problems Get Third Vaccine Doses?
France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own.
Coronavirus Briefing: What Happened Today
Our Southeast Asia bureau chief breaks down the region’s pandemic reality.
Latest Monoclonal Antibody Treatment Approved for High-Risk Patients
The drug, from GlaxoSmithKline and Vir, aims to keep those who have contracted the disease out of the hospital.
Latest Monoclonal Antibody Treatment Approved for High-Risk Patients
The drug, from GlaxoSmithKline and Vir, aims to keep those who have contracted the disease out of the hospital.
Latest Monoclonal Antibody Treatment Approved for High-Risk Patients
The drug, from GlaxoSmithKline and Vir, aims to keep those who have contracted the disease out of the hospital.
Latest Monoclonal Antibody Treatment Approved for High-Risk Patients
The drug, from GlaxoSmithKline and Vir, aims to keep Covid patients out of the hospital.
Vaccines Won’t Protect Millions of Patients With Weakened Immune Systems
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Vaccines Won’t Protect Millions of Patients With Weakened Immune Systems
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Vaccines Won’t Protect Millions of Patients With Crippled Immune Systems
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Una vacuna de bajo costo contra la COVID-19 está en marcha
Una nueva formulación que está entrando en ensayos clínicos en Brasil, México, Tailandia y Vietnam podría cambiar la forma en que el mundo combate la pandemia.
Una vacuna de bajo costo contra la COVID-19 está en marcha
Una nueva formulación que está entrando en ensayos clínicos en Brasil, México, Tailandia y Vietnam podría cambiar la forma en que el mundo combate la pandemia.
Researchers Are Hatching a Low-Cost Covid-19 Vaccine
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
Researchers Are Hatching a Low-Cost Covid-19 Vaccine
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
Researchers Are Hatching a Low-Cost Coronavirus Vaccine
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
Gilead Expands its Collaboration with AbCellera to Develop Antibodies Against Multiple Indications
Shots: AbCellera to receive upfront, milestone, and royalties based on the development and commercialization of Abs, emerge under the collaboration The expanded collaboration will utilize AbCellera’s technology stack, which includes Trianni Mouse and OrthoMab protein engineering platform AbCellera will generate panels of Abs against up to 8 new targets across multiple indications, selected by Gilead …
ViewPoints Interview: Lumen’s Brian Finrow Shares Insight on Need for the Cheaper Methods to Engineer Antibodies as a Treatment for COVID-19
In an interview with PharmaShots, Brian Finrow, Co-Founder and CEO of Lumen Bioscience shared his views on the critical need for a scalable and cheaper method to engineer antibodies as a potential treatment for Covid-19. He also shed light on why it is time for the industry to reevaluate plant-based biologics manufacturing as a possible …
ViewPoints Interview: Adagio Therapeutics’ Tillman Gerngross Shares Insight on the Development of Antibodies to Prevent COVID-19
In an interview with PharmaShots, Tillman Gerngross, Ph.D., Co-Founder, and CEO of Adagio Therapeutics shed light on the pre-clinical data of ADG2 and how it works on SARS-CoV-2. Shots: ADG2 showed broad and potent neutralizing activity against SARS-CoV and two SARS-related coronaviruses currently known to be circulating in bat populations (WIV-1 and SHC014) The company …
U.S. Buys 100,000 Doses of an Eli Lilly Antibody Treatment
The government will pay $210 million for the doses, which Eli Lilly will ship by the end of March.
U.S. Buys 100,000 Doses of an Eli Lilly Antibody Treatment
The government will pay $210 million for the doses, which Eli Lilly will ship by the end of March.
U.S. Buys 100,000 Doses of an Eli Lilly Antibody Treatment
The government will pay $210 million for the doses, which Eli Lilly will ship by the end of March.
F.D.A. Authorizes Another Antibody Treatment
Researchers hope Eli Lilly’s new combination therapy will be better able to fight virus variants than a similar treatment already in use.
F.D.A. Authorizes Another Antibody Treatment
Researchers hope Eli Lilly’s new combination therapy will be better able to fight virus variants than a similar treatment already in use.
F.D.A. Authorizes Another Antibody Treatment
Researchers hope Eli Lilly’s new combination therapy may be better able to fight virus variants than a similar treatment already in use.
Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Drug Prevents Coronavirus Infection in Nursing Homes, Maker Claims
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
What to Know of Covid-19 Antibody Drugs: Cost, Availability and More
Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.
Why Covid Antibody Drugs Go Unused as Need Soars
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.
Covid Antibody Drugs Go Unused as Need Soars
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.
Why Covid Antibody Drugs Go Unused as Need Soars
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.
What You Need to Know About the Covid Drugs That Could Help Many
Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.
What to Know of Covid-19 Antibody Drugs: Cost, Availability and More
Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.
Covid Meds Are Scarce, but Not for Trump Cronies
Rudy Giuliani got monoclonal antibodies. You probably can’t.
Covid Meds Are Scarce, but Not for Trump Cronies
Rudy Giuliani got monoclonal antibodies. You probably can’t.
Trump and Friends Got Coronavirus Care Many Others Couldn’t
Rudolph W. Giuliani became the latest in President Trump’s inner circle to boast about the treatment he received for Covid-19, as hospitals across the country ration care.
F.D.A. Grants Emergency Authorization of Antibody Treatment Given to Trump
The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease.
Model-based Strategy to Guide the Choice of Clinical Doses for ADC
Chemotherapy has been a powerful method for fighting cancer for decades. One of the most effective therapies available, it is also known for weakening the patient and causing harsh side effects like pain, nausea, and hair loss. This is because in its zeal to attack cancer cells, chemo also kills healthy cells. Enter antibody-drug conjugates …
Model-based Strategy to Guide the Choice of Clinical Doses for ADC Read More »
Qiagen to Launch Digital Test for Detecting SARS-CoV-2 Antibodies in the US
Shots: Qiagen reports the launch of the Access Anti-SARS-CoV-2 Total test that runs on a portable device and provides accurate results on Total Ig Abs (IgA, IgM, IgG) in 10mins. The device can process up to 8 samples simultaneously or up to 32 tests/hour The test was developed in collaboration with Ellume, following the US …
Qiagen to Launch Digital Test for Detecting SARS-CoV-2 Antibodies in the US Read More »
StartUPDATES: New developments from healthcare startups
News from innovative healthcare startups from Specifica, Aerovate Therapeutics and more.
English
Afrikaans
Shqip
አማርኛ
العربية
Հայերեն
Azərbaycan dili
Euskara
Беларуская мова
বাংলা
Bosanski
Български
Català
Cebuano
Chichewa
简体中文
繁體中文
Corsu
Hrvatski
Čeština
Dansk
Nederlands
Esperanto
Eesti
Filipino
Suomi
Français
Frysk
Galego
ქართული
Deutsch
Ελληνικά
ગુજરાતી
Kreyol ayisyen
Harshen Hausa
Ōlelo Hawaiʻi
עִבְרִית
हिन्दी
Hmong
Magyar
Íslenska
Igbo
Bahasa Indonesia
Gaelige
Italiano
日本語
Basa Jawa
ಕನ್ನಡ
Қазақ тілі
ភាសាខ្មែរ
한국어
كوردی
Кыргызча
ພາສາລາວ
Latin
Latviešu valoda
Lietuvių kalba
Lëtzebuergesch
Македонски јазик
Malagasy
Bahasa Melayu
മലയാളം
Maltese
Te Reo Māori
मराठी
Монгол
ဗမာစာ
नेपाली
Norsk bokmål
پښتو
فارسی
Polski
Português
ਪੰਜਾਬੀ
Română
Русский
Samoan
Gàidhlig
Српски језик
Sesotho
Shona
سنڌي
සිංහල
Slovenčina
Slovenščina
Afsoomaali
Español
Basa Sunda
Kiswahili
Svenska
Тоҷикӣ
தமிழ்
తెలుగు
ไทย
Türkçe
Українська
اردو
O‘zbekcha
Tiếng Việt
Cymraeg
isiXhosa
יידיש
Yorùbá
Zulu